| # | Drug | Count |
|---|---|---|
| 0 | CARBIDOPA AND LEVODOPA | 183 |
| 1 | ADALIMUMAB | 119 |
| 2 | TEDUGLUTIDE | 118 |
| 3 | BEVACIZUMAB | 96 |
| 4 | ERGOCALCIFEROL | 82 |
| 5 | OXALIPLATIN | 82 |
| 6 | RIVAROXABAN | 82 |
| 7 | OMEPRAZOLE MAGNESIUM | 78 |
| 8 | ACETAMINOPHEN | 77 |
| 9 | ASPIRIN | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | 1 | 0.0667 |
| 1 | BARRIER CREAM | 1 | 0.0588 |
| 2 | MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM | 1 | 0.0154 |
| 3 | ESTRONE | 1 | 0.0093 |
| 4 | TEDUGLUTIDE | 118 | 0.0088 |
| 5 | MENADIONE | 1 | 0.0072 |
| 6 | TERLIPRESSIN | 2 | 0.0060 |
| 7 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 8 | INFLIXIMAB-DYYB | 17 | 0.0049 |
| 9 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatic Amino Acid [EPC] | 202 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 147 |
| 2 | Factor Xa Inhibitor [EPC] | 143 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 126 |
| 4 | Proton Pump Inhibitor [EPC] | 120 |
| 5 | GLP-2 Analog [EPC] | 118 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 110 |
| 7 | Corticosteroid [EPC] | 97 |
| 8 | Benzodiazepine [EPC] | 91 |
| 9 | Platinum-based Drug [EPC] | 84 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 118 | 0.0088 |
| 1 | Vasopressin Receptor Agonist [EPC] | 2 | 0.0060 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 24 | 0.0048 |
| 3 | Nonergot Dopamine Agonist [EPC] | 68 | 0.0044 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 5 | Aromatic Amino Acid [EPC] | 202 | 0.0033 |
| 6 | Provitamin D2 Compound [EPC] | 82 | 0.0028 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 71 | 0.0025 |
| 8 | Influenza A M2 Protein Inhibitor [EPC] | 34 | 0.0022 |
| 9 | Cholinesterase Inhibitor [EPC] | 33 | 0.0017 |